 |
answer text |
<p>Guidance for clinically extremely vulnerable individuals was published on 12 July
and outlines support for all clinically extremely vulnerable people, including those
who are immunocompromised or immunosuppressed, which is available at the following
link:</p><p><a href="https://www.gov.uk/government/publications/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19"
target="_blank">https://www.gov.uk/government/publications/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19</a></p><p>In
addition, immunosuppressed individuals are a priority cohort for research into therapeutic
and prophylaxis treatments such as monoclonal antibody therapies, novel antivirals
and repurposed compounds. Their general practitioner practice or specialist can also
provide personalised support and advice on any additional precautions.</p>
|
 |
